Christopher J. Williams’s SEC Form 4 filings over the past year reveal a pattern driven entirely by compensation events, with no open-market buying or selling across any of the three companies in which he holds positions. The 40 reported transactions span Ameriprise Financial (AMP), Union Pacific (UNP), and Clorox (CLX), but every single filing carries the “A” code, indicating a grant or award rather than a discretionary trade. In total, Williams acquired $538,264.48 worth of shares through these awards, with zero dollars attributed to either purchases or sales.
The most recent activity, dated July 28, 2026, shows a $20,624.96 award in AMP, following a larger $52,490.97 grant in UNP on July 1. This cadence has been consistent: Williams receives quarterly UNP awards—$51,784.56 on April 1 and $51,715.93 on January 2—alongside recurring AMP grants of roughly $20,625 each, typically posted in February, April, and November. The CLX filings, which appear frequently on the last day of each quarter, all carry a value of $0, suggesting nominal or non-cash awards. The absence of any “P” (purchase) or “S” (sale) codes is notable; Williams has not expressed directional conviction through the open market, instead accumulating shares solely through scheduled compensation. The recent direction is uniformly additive, though mechanically so, with the most significant dollar-value inflows concentrated in UNP.
AI-assisted summary